Key Takeaways
- Citigroup has raised its target price for Ericsson (ERICB) to SEK 95 from SEK 85, signaling increased confidence in the telecommunications giant.
- LVMH (MC) also saw an analyst upgrade, with Citigroup boosting its target to €699 from €630.
- Heineken (HEIA) reported Q3 2025 adjusted net revenue of €7.33 billion, slightly below estimates, and expects full-year adjusted operating profit growth at the low end of its +4% to +8% range.
- Akzo Nobel (AKZA) posted a Q3 2025 net loss of €194 million, significantly missing profit estimates, impacted by a €300 million provision related to a court case.
- UniCredit (UCG) exceeded Q3 2025 net income expectations, reporting €2.63 billion, and maintained its outlook for a total distribution of ≥€9.5 billion for FY25.
European markets are reacting to a flurry of corporate news this morning, including analyst target price adjustments for major players and crucial third-quarter earnings reports. Currency markets are also showing activity, with the EUR/JPY pair holding steady and the USD/CHF pair gaining ground ahead of key economic data.
Analyst Actions: Ericsson, LVMH, and AstraZeneca See Upgrades
Ericsson (ERICB) is in focus after Citigroup increased its target price for the Swedish telecom equipment maker. The new target stands at SEK 95, an uplift from the previous SEK 85, indicating a more optimistic outlook from the investment bank. This adjustment follows a period where Ericsson's performance and strategic moves have positively impacted its financial prospects.
Luxury goods conglomerate LVMH (MC) also received a positive nod from Citigroup, which raised its target price to €699 from €630. This upgrade suggests continued strength and growth potential in the high-end market.
Meanwhile, AstraZeneca (AZN) saw its target price lifted to 145p by Berenberg. Analysts cited strong pipeline readouts and substantial pipeline progress as key factors, which they believe are not yet fully reflected in the company's share price. Berenberg also increased its 2030 revenue forecast for AstraZeneca by approximately 3% to $79.0 billion, nearing the company's ambitious target of $80.0 billion.
Q3 2025 Earnings: Mixed Results for European Giants
Heineken (HEIA) reported its Q3 2025 adjusted net revenue at €7.33 billion, slightly below the estimated €7.36 billion. The brewer's organic beer volume declined by 4.3%, though this was a modest improvement compared to the estimated -4.52%. Looking ahead, Heineken now anticipates its full-year 2025 adjusted operating profit growth to be at the low end of its +4% to +8% range, and expects overall volume to decline modestly for the full year.
Paints and coatings company Akzo Nobel (AKZA) faced a challenging third quarter, reporting revenue of €2.55 billion, in line with estimates. However, the company posted a net loss of €194 million, a significant miss against the estimated profit of €164.3 million. This loss was primarily driven by a substantial €300 million provision related to an ongoing court case. Akzo Nobel now sees its FY25 adjusted EBITDA at €1.48 billion, adjusted from a prior outlook of above €1.48 billion.
In the banking sector, UniCredit (UCG) delivered a strong Q3 2025 performance, with net income reaching €2.63 billion, surpassing analyst estimates of €2.39 billion. The bank's revenue stood at €6.17 billion, exceeding the €6.0 billion estimate, supported by net interest income of €3.37 billion and net fee & commission income of €2.04 billion. UniCredit reiterated its forecast for total distribution of ≥€9.5 billion for the full year 2025.
Currency Markets: EUR/JPY and USD/CHF Movements
The EUR/JPY currency pair is treading water above the 176.00 mark, as traders await upcoming speeches from European Central Bank (ECB) officials. The Euro is holding firm amid a modest rebound in risk appetite, which is limiting demand for the safe-haven Japanese Yen.
Meanwhile, the USD/CHF pair is clinging to gains near 0.7970, with market attention now shifting towards the release of upcoming US CPI data. The US Dollar's performance is influenced by expectations surrounding potential Federal Reserve rate cuts and concerns over a partial US government shutdown. Recent Swiss consumer inflation data, showing a 0.2% decline in September's CPI, had little immediate impact on the Swiss Franc or the pair.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.